Compare Lombard (BARD) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Lombard vs Enzyme — how do they compare? Lombard trades at Rp2,277 (market cap Rp760,91M, Rp179,24M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Lombard is far larger — about 5.7× Enzyme's market cap, and Lombard's supply is capped (332,8M / 1B BARD (34%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Lombard for 9 Days and Enzyme for 28 Days on average.
| BARD | MLN | |
|---|---|---|
Market Cap | Rp760,91M | Rp134,13M |
Volume (24h) | Rp179,24M | Rp104,56M |
Circulating Supply | 332,8M / 1B BARD (34%) | 3,3M MLN |
Typical Hold Time | 9 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lombard (BARD) is trading at Rp2,369 with a market cap of Rp775.83 million, showing bearish technical signals with moving averages indicating strong selling pressure. The token has a circulating supply of 332.8 million BARD (34% of max supply) and average hold time of 9 days. Technical indicators show neutral oscillators but bearish moving averages, with key support at Rp2,163 and resistance at Rp2,383.
Overall outlook remains cautious due to bearish technical structure and limited fundamental developments. Key opportunities include potential bounce from support levels, while major risks include low liquidity (Rp775.83M market cap) and the token's early adoption phase with only 34% circulation rate.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Lombard
Lombard is developing on-chain Bitcoin capital markets to maximize Bitcoin's potential. Founded in 2024, it leads in DeFi with LBTC, the largest yield-bearing Bitcoin option. The company is building infrastructure for BTC adoption and is backed by top digital asset leaders.
Read more on BARD →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
